Partnering News

06.07.2017

Sangamo Therapeutics And Pfizer Announce That Sb-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency

06.04.2017

Spark Therapeutics Presents Updated Preliminary Data From Hemophilia B Phase 1/2 Trial Suggesting Consistent And Sustained Levels Of Factor IX Activity At The Hemostasis And Thrombosis Research Society (HTRS) 2017 Scientific Symposium

05.22.2017

Pharma Completes Patient Recruitment Of Recombinant Human Alkaline Phosphatase (Recap) Phase II Trial In Acute Kidney Injury

05.16.2017

Sangamo Receives Fast Track Designation From The Fda For Sb-525 Investigational Hemophilia A Gene Therapy

05.16.2017

Sangamo Receives Fast Track Designation From The Fda For Sb-525 Investigational Hemophilia A Gene Therapy

05.12.2017

TNO Starts Research Initiative With Industrial Partners To Combat Obesity-Associated Liver Disease

04.27.2017

Insphero Announces Agreement With Pfizer To Develop Novel Assays For Predicting Drug-Induced Liver Injury

04.25.2017

Aquinnah Pharmaceuticals Receives $10 Million Investment from Pfizer and AbbVie to Research Breakthrough Approach to Neurodegenerative Disease

04.25.2017

Circle Pharma Announces Expansion Of Series A Financing And Appointment Of James C. Lu To Its Board

04.25.2017

Domain Therapeutics And Pfizer Inc. Enter Into Collaboration Agreement On Biosensall™

03.21.2017

NephCure Kidney International® Launches the NephCure Accelerating Cures Institute® Aims to accelerate treatments and a cure for glomerular kidney diseases

03.21.2017

New drug strategy: target the ribosome to halt protein production